Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Lymphocytes"" wg kryterium: Temat


Starter badań:

Tytuł:
Biomarkers of tumor-reactive CD4 TILs associate with improved prognosis in endometrial cancer.
Autorzy:
Palomero J; Tumor Immunology and Immunotherapy, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
Panisello C; Tumor Immunology and Immunotherapy, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
Lozano-Rabella M; Tumor Immunology and Immunotherapy, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
Tirtakasuma R; Tumor Immunology and Immunotherapy, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
Díaz-Gómez J; Tumor Immunology and Immunotherapy, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
Grases D; Tumor Immunology and Immunotherapy, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
Pasamar H; Tumor Immunology and Immunotherapy, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
Arregui L; HUB-ICO-IDIBELL Biobank, Bellvitge Institute for Biomedical Research, L'Hospitalet de Llobregat, Spain.
Dorca Duch E; Pathology, Bellvitge University Hospital, IDIBELL, L'Hospitalet de Llobregat, Spain.
Guerra Fernández E; Pathology, Bellvitge University Hospital, IDIBELL, L'Hospitalet de Llobregat, Spain.
Vivancos A; Cancer Genomics, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
de Andrea CE; Pathology, Clinica Universidad de Navarra, Pamplona, Spain.; Centro de Investigación Biomedica en Red de Cáncer (CIBERONC), Madrid, Spain.
Melero I; Centro de Investigación Biomedica en Red de Cáncer (CIBERONC), Madrid, Spain.; Program of Immunology and Immunotherapy, CIMA Universidad de Navarra, Pamplona, Spain.; Navarra Institute for Health Research IDISNA, Pamplona, Spain.
Ponce J; Department of Gynaecology, Bellvitge University Hospital, L'Hospitalet de Llobregat, Spain.
Vidal A; Pathology, Bellvitge University Hospital, IDIBELL, L'Hospitalet de Llobregat, Spain.; Centro de Investigación Biomedica en Red de Cáncer (CIBERONC), Madrid, Spain.
Piulats JM; Medical Oncology, Catalan Institute of Oncology (ICO), IDIBELL-OncoBell, L'Hospitalet de Llobregat, Spain.
Matias-Guiu X; Pathology, Bellvitge University Hospital, IDIBELL, L'Hospitalet de Llobregat, Spain.; Centro de Investigación Biomedica en Red de Cáncer (CIBERONC), Madrid, Spain.; Pathology, Arnau de Vilanova University Hospital, University of LLeida, IRBLLEIDA, Lleida, Spain.
Gros A; Tumor Immunology and Immunotherapy, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain .
Pokaż więcej
Źródło:
Journal for immunotherapy of cancer [J Immunother Cancer] 2022 Dec; Vol. 10 (12).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Lymphocytes, Tumor-Infiltrating*
Endometrial Neoplasms*/metabolism
Humans ; Female ; Programmed Cell Death 1 Receptor ; CD8-Positive T-Lymphocytes ; Prognosis ; Biomarkers, Tumor/metabolism ; CD4-Positive T-Lymphocytes/metabolism
Czasopismo naukowe
Tytuł:
CD4 helper T cells endow cDC1 with cancer-impeding functions in the human tumor micro-environment.
Autorzy:
Lei X; Department of Immunology, Leiden University Medical Center, Leiden, The Netherlands.; Oncode Institute, Leiden University Medical Center, Leiden, The Netherlands.
Khatri I; Department of Immunology, Leiden University Medical Center, Leiden, The Netherlands.
de Wit T; Department of Immunology, Leiden University Medical Center, Leiden, The Netherlands.; Oncode Institute, Leiden University Medical Center, Leiden, The Netherlands.
de Rink I; Genomics Facility, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Nieuwland M; Genomics Facility, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Kerkhoven R; Genomics Facility, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
van Eenennaam H; Aduro Biotech Europe B.V, Oss, The Netherlands.
Sun C; Immune Regulation in Cancer, German Cancer Research Center, Heidelberg, Germany.
Garg AD; Laboratory of Cell Stress & Immunity, Department of Cellular & Molecular Medicine, KU Leuven, Leuven, Belgium.
Borst J; Department of Immunology, Leiden University Medical Center, Leiden, The Netherlands. .; Oncode Institute, Leiden University Medical Center, Leiden, The Netherlands. .
Xiao Y; Department of Immunology, Leiden University Medical Center, Leiden, The Netherlands. .; Oncode Institute, Leiden University Medical Center, Leiden, The Netherlands. .
Pokaż więcej
Źródło:
Nature communications [Nat Commun] 2023 Jan 13; Vol. 14 (1), pp. 217. Date of Electronic Publication: 2023 Jan 13.
Typ publikacji:
Journal Article
MeSH Terms:
CD8-Positive T-Lymphocytes*
Neoplasms*/metabolism
Humans ; Antigen Presentation ; T-Lymphocytes, Cytotoxic ; Dendritic Cells ; T-Lymphocytes, Helper-Inducer/metabolism ; Tumor Microenvironment
Czasopismo naukowe
Tytuł:
Differential CpG DNA methylation of peripheral B cells, CD4 T cells, and salivary gland tissues in IgG4-related disease.
Autorzy:
Wu X; Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.; Clinical Biobank, Department of Medical Research Center, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
Wang A; Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.; National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology; State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.; Key Laboratory of Rheumatology & Clinical Immunology, Ministry of Education, Beijing, 100730, China.
Wang M; Department of Stomatology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
Peng Y; Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.; National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology; State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.; Key Laboratory of Rheumatology & Clinical Immunology, Ministry of Education, Beijing, 100730, China.
Chen Y; Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.; National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology; State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.; Key Laboratory of Rheumatology & Clinical Immunology, Ministry of Education, Beijing, 100730, China.
Li J; Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.; National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology; State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.; Key Laboratory of Rheumatology & Clinical Immunology, Ministry of Education, Beijing, 100730, China.
Liu Z; Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.; National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology; State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.; Key Laboratory of Rheumatology & Clinical Immunology, Ministry of Education, Beijing, 100730, China.
Lu H; Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.; National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology; State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.; Key Laboratory of Rheumatology & Clinical Immunology, Ministry of Education, Beijing, 100730, China.
Zhou J; Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.; National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology; State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.; Key Laboratory of Rheumatology & Clinical Immunology, Ministry of Education, Beijing, 100730, China.
Peng L; Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.; National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology; State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.; Key Laboratory of Rheumatology & Clinical Immunology, Ministry of Education, Beijing, 100730, China.
Zhao Y; Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.; National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology; State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.; Key Laboratory of Rheumatology & Clinical Immunology, Ministry of Education, Beijing, 100730, China.
Zeng X; Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.; National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology; State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.; Key Laboratory of Rheumatology & Clinical Immunology, Ministry of Education, Beijing, 100730, China.
Fei Y; Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. .; National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology; State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. .; Key Laboratory of Rheumatology & Clinical Immunology, Ministry of Education, Beijing, 100730, China. .
Zhang W; Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. .; National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology; State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. .; Key Laboratory of Rheumatology & Clinical Immunology, Ministry of Education, Beijing, 100730, China. .
Pokaż więcej
Źródło:
Arthritis research & therapy [Arthritis Res Ther] 2023 Jan 07; Vol. 25 (1), pp. 4. Date of Electronic Publication: 2023 Jan 07.
Typ publikacji:
Journal Article
MeSH Terms:
Immunoglobulin G4-Related Disease*/genetics
T-Lymphocytes*
B-Lymphocytes*
Humans ; CD4-Positive T-Lymphocytes ; DNA Methylation/genetics ; Fibrosis ; Salivary Glands/metabolism
Czasopismo naukowe
Tytuł:
Monitoring anti-CD19 chimeric antigen receptor T cell population by flow cytometry and its consistency with digital droplet polymerase chain reaction.
Autorzy:
Cheng J; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Mao X; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Chen C; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Long X; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Chen L; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Zhou J; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Zhu L; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Pokaż więcej
Źródło:
Cytometry. Part A : the journal of the International Society for Analytical Cytology [Cytometry A] 2023 Jan; Vol. 103 (1), pp. 16-26. Date of Electronic Publication: 2022 Aug 05.
Typ publikacji:
Journal Article
MeSH Terms:
Receptors, Chimeric Antigen*/genetics
T-Lymphocytes*
Antibodies ; B-Lymphocytes ; Flow Cytometry/methods ; Lymphocytes ; Humans
Czasopismo naukowe
Tytuł:
Regulatory T-cell-derived interleukin-15 shapes cytotoxic T cell memory.
Autorzy:
Geginat J; University of Milan, Department of Clinical Sciences and Community Health, Milan, Italy.; Fondazione Istituto Nazionale di Genetica Molecolare 'Romeo ed Enrica Invernizzi', Milan, Italy.
Granucci F; University of Milano-Bicocca, Department of Biotechnology and Biosciences, Milan, Italy.
Pokaż więcej
Źródło:
European journal of immunology [Eur J Immunol] 2023 Jan; Vol. 53 (1), pp. e2250238. Date of Electronic Publication: 2022 Dec 08.
Typ publikacji:
Journal Article
MeSH Terms:
T-Lymphocytes, Regulatory*
Antineoplastic Agents*
Mice ; Humans ; Animals ; T-Lymphocytes, Cytotoxic ; Interleukin-15 ; Memory T Cells ; CD8-Positive T-Lymphocytes ; Forkhead Transcription Factors ; Interleukin-2
Czasopismo naukowe
Tytuł:
Biology and clinical relevance of follicular cytotoxic T cells.
Autorzy:
Lv Y; Bone Marrow Transplantation Center, The First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.; Liangzhu Laboratory of Zhejiang University Medical Center, Hangzhou, Zhejiang, China.; Institute of Hematology, Zhejiang University, Hangzhou, Zhejiang, China.; Zhejiang Province Stem Cell and Cellular Immunotherapy Engineering Laboratory, Hangzhou, Zhejiang, China.
Ricard L; Sorbonne Université, INSERM, Centre de Recherche Saint-Antoine (CRSA), Paris, France.; AP-HP, Hôpital Saint-Antoine, Service d'Hématologie Clinique et Thérapie Cellulaire, Sorbonne Université, Paris, France.
Gaugler B; Sorbonne Université, INSERM, Centre de Recherche Saint-Antoine (CRSA), Paris, France.; AP-HP, Hôpital Saint-Antoine, Service d'Hématologie Clinique et Thérapie Cellulaire, Sorbonne Université, Paris, France.
Huang H; Bone Marrow Transplantation Center, The First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.; Liangzhu Laboratory of Zhejiang University Medical Center, Hangzhou, Zhejiang, China.; Institute of Hematology, Zhejiang University, Hangzhou, Zhejiang, China.; Zhejiang Province Stem Cell and Cellular Immunotherapy Engineering Laboratory, Hangzhou, Zhejiang, China.
Ye Y; Bone Marrow Transplantation Center, The First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.; Liangzhu Laboratory of Zhejiang University Medical Center, Hangzhou, Zhejiang, China.; Institute of Hematology, Zhejiang University, Hangzhou, Zhejiang, China.; Zhejiang Province Stem Cell and Cellular Immunotherapy Engineering Laboratory, Hangzhou, Zhejiang, China.
Pokaż więcej
Źródło:
Frontiers in immunology [Front Immunol] 2022 Dec 14; Vol. 13, pp. 1036616. Date of Electronic Publication: 2022 Dec 14 (Print Publication: 2022).
Typ publikacji:
Journal Article; Review; Research Support, Non-U.S. Gov't
MeSH Terms:
T-Lymphocytes, Cytotoxic*
CD8-Positive T-Lymphocytes*
Clinical Relevance ; B-Lymphocytes ; Biology
Czasopismo naukowe
Tytuł:
Engineered T cell therapy for viral and non-viral epithelial cancers.
Autorzy:
Norberg SM; National Cancer Institute, Center for Immuno-Oncology, Bethesda, MD 20892, USA.
Hinrichs CS; Rutgers Cancer Institute of New Jersey, Duncan and Nancy MacMillan Cancer Immunology and Metabolism Center of Excellence, New Brunswick, NJ 08901, USA. Electronic address: .
Pokaż więcej
Źródło:
Cancer cell [Cancer Cell] 2023 Jan 09; Vol. 41 (1), pp. 58-69. Date of Electronic Publication: 2022 Nov 17.
Typ publikacji:
Journal Article; Review
MeSH Terms:
T-Lymphocytes*
Neoplasms*
Humans ; Immunotherapy, Adoptive ; Receptors, Antigen, T-Cell ; Lymphocytes, Tumor-Infiltrating
Czasopismo naukowe
Tytuł:
Technology meets TILs: Deciphering T cell function in the -omics era.
Autorzy:
Hudson WH; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA; Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX 77030, USA. Electronic address: .
Wieland A; Department of Otolaryngology, The Ohio State University, Columbus, OH 43210, USA; Department of Microbial Infection and Immunity, The Ohio State University, Columbus, OH 43210, USA; Pelotonia Institute for Immuno-Oncology, The Ohio State University, Columbus, OH 43210, USA. Electronic address: .
Pokaż więcej
Źródło:
Cancer cell [Cancer Cell] 2023 Jan 09; Vol. 41 (1), pp. 41-57. Date of Electronic Publication: 2022 Oct 06.
Typ publikacji:
Journal Article; Review
MeSH Terms:
CD8-Positive T-Lymphocytes*
Neoplasms*/genetics
Neoplasms*/therapy
Humans ; Immunotherapy ; Lymphocytes, Tumor-Infiltrating ; Tumor Microenvironment
Czasopismo naukowe
Tytuł:
Peripheral double negative T: A look at senescent Cubans.
Autorzy:
Marrero YT; Department of Immunology, 'José Manuel Ballester Santovenia' Institute of Hematology and Immunology, Calle 19 e/8 y 10, PO Box 8070, Vedado, CP 10800 Havana, Cuba. Electronic address: .
Suárez VM; Department of Immunology, 'José Manuel Ballester Santovenia' Institute of Hematology and Immunology, Calle 19 e/8 y 10, PO Box 8070, Vedado, CP 10800 Havana, Cuba. Electronic address: .
Abraham CMM; Department of Immunology, 'José Manuel Ballester Santovenia' Institute of Hematology and Immunology, Calle 19 e/8 y 10, PO Box 8070, Vedado, CP 10800 Havana, Cuba. Electronic address: .
Hernández IC; Department of Immunology, 'José Manuel Ballester Santovenia' Institute of Hematology and Immunology, Calle 19 e/8 y 10, PO Box 8070, Vedado, CP 10800 Havana, Cuba. Electronic address: .
Ramos EH; Department of Immunology, 'José Manuel Ballester Santovenia' Institute of Hematology and Immunology, Calle 19 e/8 y 10, PO Box 8070, Vedado, CP 10800 Havana, Cuba. Electronic address: .
Domínguez GD; Department of Immunology, 'José Manuel Ballester Santovenia' Institute of Hematology and Immunology, Calle 19 e/8 y 10, PO Box 8070, Vedado, CP 10800 Havana, Cuba. Electronic address: .
Pérez YD; Department of Immunology, 'José Manuel Ballester Santovenia' Institute of Hematology and Immunology, Calle 19 e/8 y 10, PO Box 8070, Vedado, CP 10800 Havana, Cuba. Electronic address: .
Zamora MCR; National Center for Biopreparations, Bejucal, Mayabeque, Cuba. Electronic address: .
Pita AMS; Department of Immunology, 'José Manuel Ballester Santovenia' Institute of Hematology and Immunology, Calle 19 e/8 y 10, PO Box 8070, Vedado, CP 10800 Havana, Cuba. Electronic address: .
Guerra LFH; Subdirectorate of Medical Assistance, Research Center for the Elderly (CITED), Vedado, Havana, Cuba. Electronic address: .
Pokaż więcej
Źródło:
Experimental gerontology [Exp Gerontol] 2023 Jan; Vol. 171, pp. 112006. Date of Electronic Publication: 2022 Nov 02.
Typ publikacji:
Journal Article
MeSH Terms:
T-Lymphocytes*
Immunosenescence*
Female ; Male ; Animals ; Cross-Sectional Studies ; Flow Cytometry ; Lymphocytes
Czasopismo naukowe
Tytuł:
Cultivation of Encapsulated Primary Human B Lymphocytes: A First Step toward a Bioartificial Germinal Center.
Autorzy:
Helm M; Process Biotechnology, University of Bayreuth, 95447, Bayreuth, Germany.
Huang SB; Process Biotechnology, University of Bayreuth, 95447, Bayreuth, Germany.
Gollner K; Praxis am Schießgraben, Schießgraben 21, 95326, Kulmbach, Germany.
Gollner U; Praxis am Schießgraben, Schießgraben 21, 95326, Kulmbach, Germany.
Jérôme V; Process Biotechnology, University of Bayreuth, 95447, Bayreuth, Germany.
Freitag R; Process Biotechnology, University of Bayreuth, 95447, Bayreuth, Germany.
Pokaż więcej
Źródło:
Macromolecular bioscience [Macromol Biosci] 2023 Jan; Vol. 23 (1), pp. e2200256. Date of Electronic Publication: 2022 Nov 15.
Typ publikacji:
Journal Article
MeSH Terms:
B-Lymphocytes*
Germinal Center*
Humans ; Capsules ; Organoids ; T-Lymphocytes ; Cell Differentiation
Czasopismo naukowe
Tytuł:
Immune response in colorectal carcinoma: a review of its significance as a predictive and prognostic biomarker.
Autorzy:
Bell PD; Department of Pathology, University of Pittsburgh Medical Centre, Pittsburgh, PA, USA.
Pai RK; Department of Pathology, University of Pittsburgh Medical Centre, Pittsburgh, PA, USA.
Pokaż więcej
Źródło:
Histopathology [Histopathology] 2022 Dec; Vol. 81 (6), pp. 696-714. Date of Electronic Publication: 2022 Jul 15.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Lymphocytes, Tumor-Infiltrating*/pathology
Colorectal Neoplasms*/pathology
Humans ; Prognosis ; Lymphocyte Count ; Immunity ; CD8-Positive T-Lymphocytes
Czasopismo naukowe
Tytuł:
Predictive value of tumor-infiltrating lymphocytes detected by flow cytometry in colorectal cancer.
Autorzy:
Hu Y; Department of Molecular Pathology, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China; Henan Key Laboratory of Molecular Pathology, Zhengzhou, China.
Zhao J; Department of Molecular Pathology, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China; Henan Key Laboratory of Molecular Pathology, Zhengzhou, China; Department of Microbiology and Immunology, College of Basic Medical Sciences, Zhengzhou University, Zhengzhou, China.
Shen Y; Central Laboratory, Suzhou Ninth People's Hospital, Suzhou, China.
Zhang C; Center of Repository, The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China.
Xia Q; Department of Pathology, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China.
Zhang G; Department of General Surgery, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China.
Wang B; Department of Molecular Pathology, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China; Henan Key Laboratory of Molecular Pathology, Zhengzhou, China.
Wei B; Department of Molecular Pathology, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China.
Yu R; Department of Dermatology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China. Electronic address: .
Ma J; Department of Molecular Pathology, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China; Henan Key Laboratory of Molecular Pathology, Zhengzhou, China; Center of Repository, The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China. Electronic address: .
Guo Y; Department of Molecular Pathology, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China; Henan Key Laboratory of Molecular Pathology, Zhengzhou, China. Electronic address: .
Pokaż więcej
Źródło:
International immunopharmacology [Int Immunopharmacol] 2022 Dec; Vol. 113 (Pt A), pp. 109286. Date of Electronic Publication: 2022 Oct 15.
Typ publikacji:
Journal Article
MeSH Terms:
Lymphocytes, Tumor-Infiltrating*
Colorectal Neoplasms*/pathology
Humans ; Flow Cytometry ; CD8-Positive T-Lymphocytes ; Kaplan-Meier Estimate ; Biomarkers/metabolism ; Prognosis ; Tumor Microenvironment
Czasopismo naukowe
Tytuł:
Once upon a prime: DCs shape cancer immunity.
Autorzy:
Zagorulya M; Department of Biology, MIT, Cambridge, MA 02139, USA; Koch Institute for Integrative Cancer Research, MIT, Cambridge, MA 02139, USA.
Spranger S; Department of Biology, MIT, Cambridge, MA 02139, USA; Koch Institute for Integrative Cancer Research, MIT, Cambridge, MA 02139, USA; Ludwig Center at MIT's Koch Institute for Integrative Cancer Research, Cambridge, MA 02139, USA; Ragon Institute of MGH, MIT and Harvard, Cambridge, MA 02139, USA. Electronic address: .
Pokaż więcej
Źródło:
Trends in cancer [Trends Cancer] 2023 Feb; Vol. 9 (2), pp. 172-184. Date of Electronic Publication: 2022 Nov 07.
Typ publikacji:
Journal Article; Review
MeSH Terms:
CD8-Positive T-Lymphocytes*
Neoplasms*/pathology
Humans ; Dendritic Cells ; T-Lymphocytes, Cytotoxic ; Lymphocyte Activation ; Tumor Microenvironment
Czasopismo naukowe
Tytuł:
Immune phenotypes and checkpoint molecule expression of clonally expanded lymph node-infiltrating T cells in classical Hodgkin lymphoma.
Autorzy:
Ballhausen A; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin und Humboldt-Universität zu, Augustenburger Platz 1, 13353, Berlin, Germany.
Ben Hamza A; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin und Humboldt-Universität zu, Augustenburger Platz 1, 13353, Berlin, Germany.
Welters C; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin und Humboldt-Universität zu, Augustenburger Platz 1, 13353, Berlin, Germany.
Dietze K; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin und Humboldt-Universität zu, Augustenburger Platz 1, 13353, Berlin, Germany.
Bullinger L; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin und Humboldt-Universität zu, Augustenburger Platz 1, 13353, Berlin, Germany.; German Cancer Consortium (DKTK), Berlin, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany.
Rahn HP; Preparative Flow Cytometry, Max-Delbrück-Centrum für Molekulare Medizin, Berlin, Germany.
Hartmann S; Dr. Senckenberg Institute of Pathology, Goethe University Frankfurt, Frankfurt am Main, Germany.
Hansmann ML; Frankfurt Institute of Advanced Studies, Frankfurt am Main, Germany.; Institute of General Pharmacology and Toxicology, Goethe University Frankfurt, Frankfurt am Main, Germany.
Hansmann L; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin und Humboldt-Universität zu, Augustenburger Platz 1, 13353, Berlin, Germany. .; German Cancer Consortium (DKTK), Berlin, Germany. .; German Cancer Research Center (DKFZ), Heidelberg, Germany. .
Pokaż więcej
Źródło:
Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2023 Feb; Vol. 72 (2), pp. 515-521. Date of Electronic Publication: 2022 Aug 10.
Typ publikacji:
Journal Article
MeSH Terms:
Hodgkin Disease*/pathology
Lymphocytes, Tumor-Infiltrating*
Humans ; CD8-Positive T-Lymphocytes ; Immune Checkpoint Inhibitors/therapeutic use ; Lymph Nodes ; Phenotype ; Tumor Microenvironment
Czasopismo naukowe
Tytuł:
Decreased ratio of FOXP3 T cells in peripheral blood is associated with unexplained infertility and ART failure.
Autorzy:
Velichkov A; Laboratory of Reproductive OMICs Technologies, Institute of Biology and Immunology of Reproduction 'Acad. Kiril Bratanov', Bulgarian Academy of Sciences, Sofia, Bulgaria.
Susurkova R; Laboratory of Reproductive OMICs Technologies, Institute of Biology and Immunology of Reproduction 'Acad. Kiril Bratanov', Bulgarian Academy of Sciences, Sofia, Bulgaria.
Muhtarova M; National Specialized Hospital for Active Treatment of Hematological Diseases, Sofia, Bulgaria.
Guenova M; National Specialized Hospital for Active Treatment of Hematological Diseases, Sofia, Bulgaria.
Muylder BC; Institut Cochin, INSERM U1016, CNRS UMR8104, Universite de Paris, Paris, France.
Cheynier R; Institut Cochin, INSERM U1016, CNRS UMR8104, Universite de Paris, Paris, France.
Nikolov G; Medical Center 'Reprobiomed', Sofia, Bulgaria.
Konova E; Medical University-Pleven, Bulgaria.
Terzieva V; Laboratory of Reproductive OMICs Technologies, Institute of Biology and Immunology of Reproduction 'Acad. Kiril Bratanov', Bulgarian Academy of Sciences, Sofia, Bulgaria; University Hospital 'Lozenetz', Faculty of Medicine, Sofia University 'Sv. Kliment Ohridski', Sofia, Bulgaria. Electronic address: velislava_.
Pokaż więcej
Źródło:
Journal of reproductive immunology [J Reprod Immunol] 2023 Feb; Vol. 155, pp. 103793. Date of Electronic Publication: 2022 Dec 30.
Typ publikacji:
Journal Article
MeSH Terms:
T-Lymphocytes, Regulatory*/metabolism
Infertility*
Pregnancy ; Humans ; Female ; CD4-Positive T-Lymphocytes/metabolism ; Leukocyte Common Antigens/metabolism ; Immune Tolerance ; Forkhead Transcription Factors/metabolism
Czasopismo naukowe
Tytuł:
Tumor-infiltrating lymphocytes and macrophages as a significant prognostic factor in biliary tract cancer.
Autorzy:
Tanaka R; Department of Hepato-Biliary-Pancreatic Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan.; Department of Gastroenterological Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan.; Department of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, United States of America.
Eguchi S; Department of Hepato-Biliary-Pancreatic Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan.
Kimura K; Department of Hepato-Biliary-Pancreatic Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan.
Ohira G; Department of Hepato-Biliary-Pancreatic Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan.
Tanaka S; Department of Hepato-Biliary-Pancreatic Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan.
Amano R; Department of Hepato-Biliary-Pancreatic Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan.
Tanaka H; Department of Gastroenterological Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan.
Yashiro M; Department of Gastroenterological Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan.; Molecular Oncology and Therapeutics, Osaka City University Graduate School of Medicine, Osaka, Japan.; Cancer Center for Translational Research, Osaka City University Graduate School of Medicine, Osaka, Japan.
Ohira M; Department of Gastroenterological Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan.
Kubo S; Department of Hepato-Biliary-Pancreatic Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2023 Jan 24; Vol. 18 (1), pp. e0280348. Date of Electronic Publication: 2023 Jan 24 (Print Publication: 2023).
Typ publikacji:
Journal Article
MeSH Terms:
Lymphocytes, Tumor-Infiltrating*
Biliary Tract Neoplasms*/surgery
Biliary Tract Neoplasms*/pathology
Humans ; Prognosis ; Retrospective Studies ; CD8-Positive T-Lymphocytes ; Macrophages ; Tumor Microenvironment
Czasopismo naukowe
Tytuł:
IFNγ signaling in cytotoxic T cells restricts anti-tumor responses by inhibiting the maintenance and diversity of intra-tumoral stem-like T cells.
Autorzy:
Mazet JM; The Kennedy Institute of Rheumatology, University of Oxford, Oxford, UK.
Mahale JN; The Kennedy Institute of Rheumatology, University of Oxford, Oxford, UK.
Tong O; Department of Oncology, University of Oxford, Oxford, UK.
Watson RA; Department of Oncology, University of Oxford, Oxford, UK.
Lechuga-Vieco AV; The Kennedy Institute of Rheumatology, University of Oxford, Oxford, UK.
Pirgova G; The Kennedy Institute of Rheumatology, University of Oxford, Oxford, UK.
Lau VWC; The Kennedy Institute of Rheumatology, University of Oxford, Oxford, UK.
Attar M; The Kennedy Institute of Rheumatology, University of Oxford, Oxford, UK.
Koneva LA; The Kennedy Institute of Rheumatology, University of Oxford, Oxford, UK.
Sansom SN; The Kennedy Institute of Rheumatology, University of Oxford, Oxford, UK.
Fairfax BP; Department of Oncology, University of Oxford, Oxford, UK.
Gérard A; The Kennedy Institute of Rheumatology, University of Oxford, Oxford, UK. .
Pokaż więcej
Źródło:
Nature communications [Nat Commun] 2023 Jan 19; Vol. 14 (1), pp. 321. Date of Electronic Publication: 2023 Jan 19.
Typ publikacji:
Journal Article
MeSH Terms:
T-Lymphocytes, Cytotoxic*/metabolism
Melanoma*/therapy
Melanoma*/drug therapy
Mice ; Animals ; CD8-Positive T-Lymphocytes ; Clone Cells/metabolism
Czasopismo naukowe
Tytuł:
Impact of SARS-CoV-2 exposure history on the T cell and IgG response.
Autorzy:
Keeton R; Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa; Division of Medical Virology, Department of Pathology, University of Cape Town, Cape Town, South Africa.
Tincho MB; Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa; Division of Medical Virology, Department of Pathology, University of Cape Town, Cape Town, South Africa.
Suzuki A; Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa; Division of Medical Virology, Department of Pathology, University of Cape Town, Cape Town, South Africa.
Benede N; Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa; Division of Medical Virology, Department of Pathology, University of Cape Town, Cape Town, South Africa.
Ngomti A; Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa; Division of Medical Virology, Department of Pathology, University of Cape Town, Cape Town, South Africa.
Baguma R; Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa; Division of Medical Virology, Department of Pathology, University of Cape Town, Cape Town, South Africa.
Chauke MV; Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa; Division of Medical Virology, Department of Pathology, University of Cape Town, Cape Town, South Africa.
Mennen M; Department of Medicine, University of Cape Town and Groote Schuur Hospital, Cape Town, South Africa; Cape Heart Institute, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa; South African Medical Research Council Extramural Unit on Intersection of Non-communicable Diseases and Infectious Diseases, University of Cape Town, Cape Town, South Africa.
Skelem S; Department of Medicine, University of Cape Town and Groote Schuur Hospital, Cape Town, South Africa; Cape Heart Institute, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa; South African Medical Research Council Extramural Unit on Intersection of Non-communicable Diseases and Infectious Diseases, University of Cape Town, Cape Town, South Africa.
Adriaanse M; Department of Medicine, University of Cape Town and Groote Schuur Hospital, Cape Town, South Africa; Cape Heart Institute, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa; South African Medical Research Council Extramural Unit on Intersection of Non-communicable Diseases and Infectious Diseases, University of Cape Town, Cape Town, South Africa.
Grifoni A; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA, USA.
Weiskopf D; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA, USA.
Sette A; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA, USA; Department of Medicine, Division of Infectious Diseases and Global Public Health, University of California, San Diego (UCSD), La Jolla, CA, USA.
Bekker LG; Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa; Department of Medicine, University of Cape Town and Groote Schuur Hospital, Cape Town, South Africa; Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa.
Gray G; South African Medical Research Council, Cape Town, South Africa.
Ntusi NAB; Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa; Department of Medicine, University of Cape Town and Groote Schuur Hospital, Cape Town, South Africa; Cape Heart Institute, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa; South African Medical Research Council Extramural Unit on Intersection of Non-communicable Diseases and Infectious Diseases, University of Cape Town, Cape Town, South Africa; Wellcome Centre for Infectious Diseases Research in Africa, University of Cape Town, Cape Town, South Africa.
Burgers WA; Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa; Division of Medical Virology, Department of Pathology, University of Cape Town, Cape Town, South Africa; Wellcome Centre for Infectious Diseases Research in Africa, University of Cape Town, Cape Town, South Africa. Electronic address: .
Riou C; Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa; Division of Medical Virology, Department of Pathology, University of Cape Town, Cape Town, South Africa; Wellcome Centre for Infectious Diseases Research in Africa, University of Cape Town, Cape Town, South Africa. Electronic address: .
Pokaż więcej
Źródło:
Cell reports. Medicine [Cell Rep Med] 2023 Jan 17; Vol. 4 (1), pp. 100898. Date of Electronic Publication: 2022 Dec 22.
Typ publikacji:
Journal Article
MeSH Terms:
COVID-19*/epidemiology
Immunoglobulin G*
T-Lymphocytes*
Humans ; Antibody Formation ; CD4-Positive T-Lymphocytes ; SARS-CoV-2
Czasopismo naukowe
Tytuł:
SARS-CoV-2 escape from cytotoxic T cells during long-term COVID-19.
Autorzy:
Stanevich OV; Smorodintsev Research Institute of Influenza, Saint-Petersburg, Russia.
Alekseeva EI; Skolkovo Institute of Science and Technology (Skoltech), Moscow, Russia. .
Sergeeva M; Smorodintsev Research Institute of Influenza, Saint-Petersburg, Russia.
Fadeev AV; Smorodintsev Research Institute of Influenza, Saint-Petersburg, Russia.
Komissarova KS; Smorodintsev Research Institute of Influenza, Saint-Petersburg, Russia.
Ivanova AA; Smorodintsev Research Institute of Influenza, Saint-Petersburg, Russia.
Simakova TS; Parseq Lab Co. Ltd, Saint Petersburg, Russia.
Vasilyev KA; Smorodintsev Research Institute of Influenza, Saint-Petersburg, Russia.
Shurygina AP; Smorodintsev Research Institute of Influenza, Saint-Petersburg, Russia.
Stukova MA; Smorodintsev Research Institute of Influenza, Saint-Petersburg, Russia.
Safina KR; Skolkovo Institute of Science and Technology (Skoltech), Moscow, Russia.
Nabieva ER; A.A. Kharkevich Institute for Information Transmission Problems of the Russian Academy of Sciences, Moscow, Russia.
Garushyants SK; A.A. Kharkevich Institute for Information Transmission Problems of the Russian Academy of Sciences, Moscow, Russia.; National Center for Biotechnology Information, National Library of Medicine, National Institutes of Health, Bethesda, MD, USA.
Klink GV; A.A. Kharkevich Institute for Information Transmission Problems of the Russian Academy of Sciences, Moscow, Russia.
Bakin EA; First Pavlov State Medical University, Saint-Petersburg, Russia.; Bioinformatics Institute, Saint Petersburg, Russia.
Zabutova JV; City Hospital 31, Saint-Petersburg, Russia.
Kholodnaia AN; First Pavlov State Medical University, Saint-Petersburg, Russia.; City Hospital 31, Saint-Petersburg, Russia.
Lukina OV; First Pavlov State Medical University, Saint-Petersburg, Russia.
Skorokhod IA; City Hospital 31, Saint-Petersburg, Russia.
Ryabchikova VV; City Hospital 31, Saint-Petersburg, Russia.
Medvedeva NV; City Hospital 31, Saint-Petersburg, Russia.
Lioznov DA; Smorodintsev Research Institute of Influenza, Saint-Petersburg, Russia.; First Pavlov State Medical University, Saint-Petersburg, Russia.
Danilenko DM; Smorodintsev Research Institute of Influenza, Saint-Petersburg, Russia.
Chudakov DM; Skolkovo Institute of Science and Technology (Skoltech), Moscow, Russia.; Center for Precision Genome Editing and Genetic Technologies for Biomedicine, Institute of Translational Medicine, Pirogov Russian National Research Medical University, Moscow, Russia.
Komissarov AB; Smorodintsev Research Institute of Influenza, Saint-Petersburg, Russia.
Bazykin GA; Skolkovo Institute of Science and Technology (Skoltech), Moscow, Russia. .; A.A. Kharkevich Institute for Information Transmission Problems of the Russian Academy of Sciences, Moscow, Russia. .
Pokaż więcej
Źródło:
Nature communications [Nat Commun] 2023 Jan 10; Vol. 14 (1), pp. 149. Date of Electronic Publication: 2023 Jan 10.
Typ publikacji:
Journal Article
MeSH Terms:
T-Lymphocytes, Cytotoxic*
COVID-19*
Humans ; SARS-CoV-2 ; CD8-Positive T-Lymphocytes ; Antibodies, Neutralizing ; Antibodies, Viral ; Spike Glycoprotein, Coronavirus
Czasopismo naukowe
Tytuł:
Fecal and Tissue Microbiota Are Associated with Tumor T-Cell Infiltration and Mesenteric Lymph Node Involvement in Colorectal Cancer.
Autorzy:
Luu K; John A. Burns School of Medicine, University of Hawai'i at Mānoa, Honolulu, HI 96813, USA.; The Vatche and Tamar Manoukian Division of Digestive Diseases, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA.; Division of Gastroenterology, Hepatology and Parenteral Nutrition, Veterans Affairs Greater Los Angeles Healthcare System, Los Angeles, CA 90073, USA.
Ye JY; The Vatche and Tamar Manoukian Division of Digestive Diseases, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA.
Lagishetty V; The Vatche and Tamar Manoukian Division of Digestive Diseases, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA.; Division of Gastroenterology, Hepatology and Parenteral Nutrition, Veterans Affairs Greater Los Angeles Healthcare System, Los Angeles, CA 90073, USA.
Liang F; The Vatche and Tamar Manoukian Division of Digestive Diseases, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA.
Hauer M; The Vatche and Tamar Manoukian Division of Digestive Diseases, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA.
Sedighian F; The Vatche and Tamar Manoukian Division of Digestive Diseases, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA.
Kwaan MR; Division of General Surgery, Department of Surgery, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA.
Kazanjian KK; Division of General Surgery, Department of Surgery, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA.
Hecht JR; Division of Hematology/Oncology, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA.
Lin AY; Division of General Surgery, Department of Surgery, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA.
Jacobs JP; The Vatche and Tamar Manoukian Division of Digestive Diseases, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA.; Division of Gastroenterology, Hepatology and Parenteral Nutrition, Veterans Affairs Greater Los Angeles Healthcare System, Los Angeles, CA 90073, USA.
Pokaż więcej
Źródło:
Nutrients [Nutrients] 2023 Jan 09; Vol. 15 (2). Date of Electronic Publication: 2023 Jan 09.
Typ publikacji:
Journal Article
MeSH Terms:
Colorectal Neoplasms*/pathology
Gastrointestinal Microbiome*/physiology
Microbiota*
T-Lymphocytes*/immunology
Humans ; Feces/microbiology ; Lymph Nodes ; RNA, Ribosomal, 16S/genetics ; Lymphocytes, Tumor-Infiltrating
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies

Prześlij opinię

Twoje opinie są dla nas bardzo ważne i mogą być niezwykle pomocne w pokazaniu nam, gdzie możemy dokonać ulepszeń. Bylibyśmy bardzo wdzięczni za poświęcenie kilku chwil na wypełnienie krótkiego formularza.

Formularz